Jarrod Saltalamacchia out 4-6 weeks following thumb surgery

2 Comments

Jarrod Saltalamacchia was diagnosed with a leg infection one week after joining the Red Sox, returned to get 13 at-bats, and has now been diagnosed with a torn left thumb ligament that will require surgery.
He won’t play again this season and will need 4-6 weeks of recovery time, which leaves him ample opportunity to be ready for spring training while adding to Saltalamacchia’s already lengthy list of health problems over the past couple years.
In between the leg infection and thumb injury Saltalamacchia impressed the Red Sox by showing that he’s conquered the throwing problems that plagued him earlier this season. “I think what we saw, we were actually kind of excited about,” manager Terry Francona told Ian Browne of MLB.com. “His running of the game and his energy behind the plate, we really liked. He came out throwing really well.”
With both Victor Martinez and Jason Varitek impending free agents the Red Sox were smart to bring in Saltalamacchia as a fallback option, particularly since he was available for pennies on the dollar from the Rangers. At the very least he figures to be in their plans next season as a backup behind the plate.

Angels sign Zack Cozart to a three-year, $38 million deal

Getty Images
1 Comment

Ken Rosenthal reports that the Angels have signed infielder Zack Cozart to a three-year, $38 million deal.

That seems like a bargain deal for Cozart, who hit .297/.385/.548 with 24 homers and 63 RBI as the Cincinnati Reds shortstop in 2017. In Anaheim, however, he will not be playing short — not with Andrelton Simmons around — so he’ll slide over to third base. He’s never played there, but you figure he can handle it.

This is a pretty nifty move for the Angels, as the other top third base options — specifically, Mike Moustakas — are likely going to cost a lot more than what they’ll be paying Cozart.

Between this, the Ian Kinsler trade and the Shohei Ohtani acquisition, the Angels are going to be sporting a very different look in 2018.